SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage ...

Clarity has signed a commercial-scale agreement with Nusano, Inc. ("Nusano") for supply of copper-64 (Cu-64 or 64Cu) isotope. The 190,000 square foot Nusano facility in West Valley City, Utah is ...

The news: Shares in clinical-stage radiopharmaceutical company Clarity Pharmaceuticals climbed in afternoon trade after the company secured a large-scale manufacturing supply agreement for its ...

Clarity Pharmaceuticals (ASX:CU6) has seen its share price rise more than 15% after signing a commercial-scale agreement with medical tech company Nusano for the supply of copper 64 – also known as Cu ...

SYDNEY, June 13, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that ...

The copper isotope Cu-64 plays an important role in medicine: it is used in imaging processes and also shows potential for cancer therapy. However, it does not occur naturally and must be produced ...

SYDNEY, April 17, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop and commercialise ...

The copper-64 supply from Nusano will complement Clarity's existing network of US-based suppliers to ensure seamless, abundant production of this diagnostic isotope as the Company is progressing a ...